The Pathoimmunobiology and Translational Implications of Targeting the PD?1 Checkpoint in Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

The Pathoimmunobiology and Translational Implications of Targeting the PD?1 Checkpoint in Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

What Biomarkers, Tumor? and Immune? Centric Mechanisms Underpin Clinical Response in CSCC?


Published

December 26, 2018

Created by

CMEducation Resources symposium

Related Presenters

Todd Schlesinger, MD, FAAD

Todd Schlesinger, MD, FAAD

Director, Dermatology and Laser Center of Charleston Clinical Research Center of the Carolinas Clinical Instructor, University at Buffalo Department of Dermatology Assistant Clincal Professor, Medical University of South Carolica Department ...